| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
,
D S Postma11,
J B Soriano12,
W Szafranski13,
J Vestbo14
1 The James Hogg iCAPTURE Center for Cardiovascular and Pulmonary Research, St Paul’s Hospital, Vancouver, British Columbia, Canada
2 Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
3 Department of Medical Statistics, GlaxoSmithKline R&D, UK
4 Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
5 Department of Medicine, Oregon Health and Science University, Portland, Oregon, USA
6 Heartlands Hospital NHS Trust, Birmingham, UK
7 University Hospital Aintree, Liverpool, UK
8 Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA
9 AstraZeneca R&D, Lund, Sweden
10 Department of Respiratory Diseases, Ghent University Hospital, Ghent, Belgium
11 Department of Pulmonology, University of Groningen, the Netherlands
12 Fundación Caubcc-Cimera, Palma de Mallorca, Balearic Islands, Spain
13 Department of Lung Diseases, Voivodeship Specialist Hospital, Radom, Poland
14 South Manchester University Hospital NHS Trust, Wythenshawe Hospital, Manchester, UK
Correspondence to:
Correspondence to:
Dr D D Sin
James Hogg iCAPTURE Center for Cardiovascular and Pulmonary Research, St Paul’s Hospital, 1081 Burrard Street, Vancouver, BC, Canada, V6Z 1Y6; dsin{at}mrl.ubc.ca
Background: Clinical studies suggest that inhaled corticosteroids reduce exacerbations and improve health status in chronic obstructive pulmonary disease (COPD). However, their effect on mortality is unknown.
Methods: A pooled analysis, based on intention to treat, of individual patient data from seven randomised trials (involving 5085 patients) was performed in which the effects of inhaled corticosteroids and placebo were compared over at least 12 months in patients with stable COPD. The end point was all-cause mortality.
Results: Overall, 4% of the participants died during a mean follow up period of 26 months. Inhaled corticosteroids reduced all-cause mortality by about 25% relative to placebo. Stratification by individual trials and adjustments for age, sex, baseline post-bronchodilator percentage predicted forced expiratory volume in 1 second, smoking status, and body mass index did not materially change the results (adjusted hazard ratio (HR) 0.73; 95% confidence interval (CI) 0.55 to 0.96). Although there was considerable overlap between subgroups in terms of effect sizes, the beneficial effect was especially noticeable in women (adjusted HR 0.46; 95% CI 0.24 to 0.91) and former smokers (adjusted HR 0.60; 95% CI 0.39 to 0.93).
Conclusions: Inhaled corticosteroids reduce all-cause mortality in COPD. Further studies are required to determine whether the survival benefits persist beyond 2–3 years.
Keywords: corticosteroids; mortality; chronic obstructive pulmonary disease; pooled analysis
Relevant Article
Thorax 2005 60: 977.
This article has been cited by other articles:
|
|
 |
|
  M. Gerhardsson de Verdier The Big Three Concept: A Way to Tackle the Health Care Crisis? Proceedings of the ATS, December 1, 2008; 5(8): 800 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Luppi, F. Franco, B. Beghe, and L. M. Fabbri Treatment of Chronic Obstructive Pulmonary Disease and Its Comorbidities Proceedings of the ATS, December 1, 2008; 5(8): 848 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Barnes Future Treatments for Chronic Obstructive Pulmonary Disease and Its Comorbidities Proceedings of the ATS, December 1, 2008; 5(8): 857 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Suissa Methodologic Shortcomings of the INSPIRE Randomized Trial Am. J. Respir. Crit. Care Med., November 15, 2008; 178(10): 1090 - 1091. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Barbier, A. Agusti, and S. Alberti Fluticasone propionate reduces bacterial airway epithelial invasion Eur. Respir. J., November 1, 2008; 32(5): 1283 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Godtfredsen, T. H. Lam, T. T. Hansel, M. E. Leon, N. Gray, C. Dresler, D. M. Burns, E. Prescott, and J. Vestbo COPD-related morbidity and mortality after smoking cessation: status of the evidence Eur. Respir. J., October 1, 2008; 32(4): 844 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Suissa Exacerbations and intent-to-treat analyses in randomised trials Eur. Respir. J., October 1, 2008; 32(4): 1117 - 1118. [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Lee, A. S. Pickard, D. H. Au, B. Bartle, and K. B. Weiss Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease Ann Intern Med, September 16, 2008; 149(6): 380 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Sin, S. F. P. Man, A. McWilliams, and S. Lam Surfactant Protein D and Bronchial Dysplasia in Smokers at High Risk of Lung Cancer Chest, September 1, 2008; 134(3): 582 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Camargo Jr, R. G. Barr, R. Chen, and F. E. Speizer Prospective Study of Inhaled Corticosteroid Use, Cardiovascular Mortality, and All-Cause Mortality in Asthmatic Women Chest, September 1, 2008; 134(3): 546 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Cooper and M. Decramer Inhaled steroids and COPD Eur. Respir. J., August 1, 2008; 32(2): 523 - 524. [Full Text] [PDF]
|
|
|
|
 |
|
 A K Johnston, D M Mannino, G W Hagan, K J Davis, and V A Kiri Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort Thorax, July 1, 2008; 63(7): 599 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. D'Urzo The "Towards a Revolution in COPD Health" study: Comparing treatment strategies Can Fam Physician, May 1, 2008; 54(5): 740 - 741. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Falk, O. A. Minai, and Z. Mosenifar Inhaled and Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2008; 5(4): 506 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Suissa, P. Ernst, K. L. Vandemheen, and S. D. Aaron Methodological issues in therapeutic trials of COPD Eur. Respir. J., May 1, 2008; 31(5): 927 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dubey and C. A. Powell Update in Lung Cancer 2007 Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 941 - 946. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Braganza, R. Chaudhuri, and N. C. Thomson Review: Treating patients with respiratory disease who smoke Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 95 - 107. [Abstract] [PDF]
|
|
|
|
|
|
D. H Au Use of {beta} blockers in patients with COPD Thorax, April 1, 2008; 63(4): 296 - 298. [Full Text] [PDF]
|
|
|
|
|
|
K. Lin, B. Watkins, T. Johnson, J. A. Rodriguez, and M. B. Barton Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: Summary of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, April 1, 2008; 148(7): 535 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Sridhar, R Taylor, S Dawson, N J Roberts, and M R Partridge A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease Thorax, March 1, 2008; 63(3): 194 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Wilt, D. Niewoehner, R. MacDonald, and R. L. Kane Management of Stable Chronic Obstructive Pulmonary Disease: A Systematic Review for a Clinical Practice Guideline Ann Intern Med, November 6, 2007; 147(9): 639 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. D'Urzo {beta}-Agonists: all the facts please Can Fam Physician, November 1, 2007; 53(11): 1884 - 1886. [Full Text] [PDF]
|
|
|
|
|
|
R. P. Young, R. Hopkins, and T. E. Eaton Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes Eur. Respir. J., October 1, 2007; 30(4): 616 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Suissa, R. McGhan, D. Niewoehner, and B. Make Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, October 1, 2007; 4(7): 535 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Rabe, S. Hurd, A. Anzueto, P. J. Barnes, S. A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 532 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Roche Where current pharmacological therapies fall short in COPD: symptom control is not enough Eur. Respir. Rev., September 1, 2007; 16(105): 98 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Celli and P. J. Barnes Exacerbations of chronic obstructive pulmonary disease Eur. Respir. J., June 1, 2007; 29(6): 1224 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Barnes, C. La Vecchia, L. M. Fabbri, M. Duerden, Y. Kupfer, S. Tessler, N. Keaney, P. Calverley, J. Anderson, and B. Celli Prevention of Death in COPD N. Engl. J. Med., May 24, 2007; 356(21): 2211 - 2214. [Full Text] [PDF]
|
|
|
|
|
|
Y. E. Miller and R. L. Keith Inhaled Corticosteroids and Lung Cancer Chemoprevention Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 636 - 637. [Full Text] [PDF]
|
|
|
|
|
|
T. Parimon, J. W. Chien, C. L. Bryson, M. B. McDonell, E. M. Udris, and D. H. Au Inhaled Corticosteroids and Risk of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 712 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Hylkema, P. J. Sterk, W. I. de Boer, and D. S. Postma Tobacco use in relation to COPD and asthma Eur. Respir. J., March 1, 2007; 29(3): 438 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Sutherland Inhaled Steroids and Outcomes in COPD: Progressing Beyond FEV1 Chest, March 1, 2007; 131(3): 648 - 649. [Full Text] [PDF]
|
|
|
|
|
|
J. B. Soriano, D. D. Sin, X. Zhang, P. G. Camp, J. A. Anderson, N. R. Anthonisen, A. S. Buist, P. S. Burge, P. M. Calverley, J. E. Connett, et al. A Pooled Analysis of FEV1 Decline in COPD Patients Randomized to Inhaled Corticosteroids or Placebo Chest, March 1, 2007; 131(3): 682 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M.A. Calverley, J. A. Anderson, B. Celli, G. T. Ferguson, C. Jenkins, P. W. Jones, J. C. Yates, J. Vestbo, and the TORCH investigators Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease N. Engl. J. Med., February 22, 2007; 356(8): 775 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Rabe Treating COPD -- The TORCH Trial, P Values, and the Dodo N. Engl. J. Med., February 22, 2007; 356(8): 851 - 854. [Full Text] [PDF]
|
|
|
|
|
|
D. E. Niewoehner and T. J. Wilt Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease: A Status Report Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 103 - 104. [Full Text] [PDF]
|
|
|
|
|
|
D M Mannino Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story. Thorax, December 1, 2006; 61(12): 1032 - 1034. [Full Text] [PDF]
|
|
|
|
|
|
P M A Calverley Caring for the burden of COPD. Thorax, October 1, 2006; 61(10): 831 - 832. [Full Text] [PDF]
|
|
|
|
|
|
D D Sin Inhaled corticosteroids and mortality in COPD Thorax, October 1, 2006; 61(10): 918 - 918. [Full Text] [PDF]
|
|
|
|
|
|
D D Sin Inhaled corticosteroids and mortality in COPD. Thorax, October 1, 2006; 61(10): 918 - 918. [Full Text] [PDF]
|
|
|
|
|
|
D. D. Sin and S.F. P. Man Cooling the Fire Within: Inhaled Corticosteroids and Cardiovascular Mortality in COPD. Chest, September 1, 2006; 130(3): 629 - 631. [Full Text] [PDF]
|
|
|
|
|
|
C. Macie, K. Wooldrage, J. Manfreda, and N. R. Anthonisen Inhaled Corticosteroids and Mortality in COPD. Chest, September 1, 2006; 130(3): 640 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Sin and S. F. P. Man Pharmacotherapy for Mortality Reduction in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, September 1, 2006; 3(7): 624 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rutten-van Molken and T. A. Lee Economic Modeling in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, September 1, 2006; 3(7): 630 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Ernst and S Suissa Inhaled corticosteroids and mortality in COPD. Thorax, August 1, 2006; 61(8): 735 - 735. [Full Text] [PDF]
|
|
|
|
|
|
R Stirling Inhaled corticosteroids and mortality in COPD: are we there yet? Thorax, August 1, 2006; 61(8): 735 - 735. [Full Text] [PDF]
|
|
|
|
 |
|
 G.B. J. Mancini, M. Etminan, B. Zhang, L. E. Levesque, J. M. FitzGerald, and J. M. Brophy Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary Disease J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2554 - 2560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe Update in chronic obstructive pulmonary disease 2005. Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1056 - 1065. [Full Text] [PDF]
|
|
|
|
|
|
G. P. Anderson COPD, asthma and C-reactive protein. Eur. Respir. J., May 1, 2006; 27(5): 874 - 876. [Full Text] [PDF]
|
|
|
|
|
|
D D Sin and S F P Man Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax, January 1, 2006; 61(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
|
|
J A Wedzicha and T A R Seemungal Inhaled corticosteroids in COPD: a light at the end of the tunnel? Thorax, December 1, 2005; 60(12): 977 - 978. [Full Text] [PDF]
|
|
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
